Clinical Trial Update: TVB 2640 for Resectable Colon Cancer Other Resectable Cancers; a Window Trial. [Phase 1]

View source ↗

Summary

A Phase 1 window trial of TVB-2640 for resectable colon cancer has been terminated according to a ClinicalTrials.gov update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• TVB-2640

Snippet

Sponsor: Mark Evers | Conditions: Colon Cancer | Phase 1 | Status: TERMINATED